An open-label, single-arm, phase 2 trial of the polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer
Journal
Cancer
Journal Volume
120
Journal Issue
7
Pages
976-982
Date Issued
2014
Author(s)
Stadler W.M.
Vaughn D.J.
Sonpavde G.
Vogelzang N.J.
Tagawa S.T.
Petrylak D.P.
Rosen P.
Mahoney J.
Modi S.
Lee P.
Ernstoff M.S.
Su W.-C.
Spira A.
Pilz K.
Vinisko R.
Schloss C.
Fritsch H.
Zhao C.
Carducci M.A.
SDGs
Publisher
John Wiley and Sons Inc
Type
journal article